President and CSO
CT
Chantibody Therapeutics Inc.
Chantibody Therapeutics develops monoclonal antibody therapies targeting life-threatening diseases, including various forms of cancer. The company focuses on enhancing patient outcomes by improving the specificity and efficacy of these therapeutics to reduce tumor growth and improve survival rates.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- Chantibody Therapeutics develops monoclonal antibody therapies targeting life-threatening diseases, including various forms of cancer. The company focuses on enhancing patient outcomes by improving the specificity and efficacy of these therapeutics to reduce tumor growth and improve survival rates.